The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-institution comparison of mitoxantrone, etoposide, and cytarabine (MEC) vs. high-dose cytarabine and mitoxantrone (Ara-C Couplets) therapy for patients with relapsed or refractory (R/R) acute myeloid leukemia.
 
Sonia Christian
No Relationships to Disclose
 
Pritesh Rajni Patel
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
 
Shawn Griffin
No Relationships to Disclose
 
Vaibhav Agrawal
No Relationships to Disclose
 
Irum Khan
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Teva
Research Funding - Takeda
 
Karen Sweiss
No Relationships to Disclose
 
Ardaman Shergill
No Relationships to Disclose
 
Heiko Konig
Consulting or Advisory Role - Pfizer
 
John G Quigley
Honoraria - Alexion Pharmaceuticals
Consulting or Advisory Role - Portola Pharmaceuticals
Research Funding - Teva (Inst)